Use Case: Optimizing Recruitment For Urgently Needed Vaccine

A late-stage biotechnology company developing a next-generation vaccine against monkeypox (Mpox) planned a comprehensive Phase 1 and Phase 2 trial. The trial aimed to enroll 350 volunteers, focusing on communities and demographic groups most impacted by the disease, specifically healthy participants aged 18 to 50. To achieve this recruitment target, the sponsor enlisted Citeline Connect along with other recruitment partners.

Citeline Connect played a crucial role in the trial, delivering 181 randomizations, which accounted for 52% of the enrollment goal, within just a few months. By spreading recruitment efforts across the entire geographical area of the study, see how Citeline Connect was able to successfully reach a diverse population of eligible participants.